Johnson & Johnson (JNJ) Shareholders’ equity 2016–2025
Johnson & Johnson (JNJ) shareholders’ equity at each fiscal year-end, per SEC filings.
$81.5BFY2025 · since FY2016: $70.4B → $81.5B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $81.5B | +14.1% |
| FY2024 | $71.5B | +3.9% |
| FY2023 | $68.8B | -10.5% |
| FY2022 | $76.8B | +3.8% |
| FY2021 | $74.0B | +17.0% |
| FY2020 | $63.3B | +6.4% |
| FY2019 | $59.5B | -0.5% |
| FY2018 | $59.8B | -0.7% |
| FY2017 | $60.2B | -14.6% |
| FY2016 | $70.4B | — |
Source: SEC XBRL filings · For reference only · Not investment advice